DE60025347D1 - Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests - Google Patents
Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-testsInfo
- Publication number
- DE60025347D1 DE60025347D1 DE60025347T DE60025347T DE60025347D1 DE 60025347 D1 DE60025347 D1 DE 60025347D1 DE 60025347 T DE60025347 T DE 60025347T DE 60025347 T DE60025347 T DE 60025347T DE 60025347 D1 DE60025347 D1 DE 60025347D1
- Authority
- DE
- Germany
- Prior art keywords
- hcg
- present
- test
- sample
- provides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000035935 pregnancy Effects 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 102000011022 Chorionic Gonadotropin Human genes 0.000 abstract 5
- 108010062540 Chorionic Gonadotropin Proteins 0.000 abstract 5
- 229940084986 human chorionic gonadotropin Drugs 0.000 abstract 5
- 102000001708 Protein Isoforms Human genes 0.000 abstract 3
- 108010029485 Protein Isoforms Proteins 0.000 abstract 3
- 210000002993 trophoblast Anatomy 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/311,428 US6927034B2 (en) | 1998-02-03 | 1999-05-13 | Methods for detecting trophoblast malignancy by HCG assay |
US311428 | 1999-05-13 | ||
PCT/US2000/013197 WO2000070094A1 (en) | 1999-05-13 | 2000-05-12 | METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60025347D1 true DE60025347D1 (de) | 2006-03-30 |
DE60025347T2 DE60025347T2 (de) | 2006-09-14 |
Family
ID=23206832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60025347T Expired - Lifetime DE60025347T2 (de) | 1999-05-13 | 2000-05-12 | Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests |
Country Status (9)
Country | Link |
---|---|
US (8) | US6927034B2 (de) |
EP (1) | EP1183390B8 (de) |
AT (1) | ATE395812T1 (de) |
AU (1) | AU778130B2 (de) |
CA (1) | CA2372666C (de) |
DE (1) | DE60025347T2 (de) |
IL (2) | IL146454A0 (de) |
NZ (1) | NZ516024A (de) |
WO (1) | WO2000070094A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6927034B2 (en) | 1998-02-03 | 2005-08-09 | The Trustees Of Columbia University In The City Of New York | Methods for detecting trophoblast malignancy by HCG assay |
US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
US7198954B1 (en) | 1999-02-03 | 2007-04-03 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by hCG assay |
JP2001349892A (ja) * | 2000-04-03 | 2001-12-21 | Unilever Nv | 検査方法及びデバイス |
US6627457B2 (en) | 2001-07-30 | 2003-09-30 | Quest Diagnostics Investments Incorporated | Methods for detecting pregnancy |
WO2003012445A1 (en) | 2001-07-30 | 2003-02-13 | Quest Diagnostics Investments Incorporated | Methods and kits for detecting ita in a biological sample |
US20030027234A1 (en) * | 2001-07-30 | 2003-02-06 | Pandian Murugan R. | Methods for detecting Down's syndrome |
US7871762B2 (en) * | 2002-10-10 | 2011-01-18 | Stc.Unm | Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease |
US7572639B2 (en) * | 2004-06-03 | 2009-08-11 | Stc.Unm | Method and apparatus for predicting pregnancy outcome |
US20060105411A1 (en) * | 2004-11-15 | 2006-05-18 | Cole Laurence A | Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally |
AU2006278260B2 (en) * | 2005-08-08 | 2012-03-08 | Onconon, Llc. | Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
RU2008145884A (ru) * | 2006-04-21 | 2010-05-27 | Бритиш Прегнанси Адвайзори Сервис (Gb) | Устройство и способ определения гормона, связанного с беременностью |
US20080182244A1 (en) * | 2006-08-04 | 2008-07-31 | Ikonisys, Inc. | Pre-Implantation Genetic Diagnosis Test |
WO2009033001A2 (en) * | 2007-09-05 | 2009-03-12 | University Of Utah Research Foundation | Robust location distinction using teporal link signatures |
WO2010030950A2 (en) * | 2008-09-12 | 2010-03-18 | University Of Utah Research Foundation | Method and system for detecting unauthorized wireless access points using clock skews |
US8818288B2 (en) * | 2010-07-09 | 2014-08-26 | University Of Utah Research Foundation | Statistical inversion method and system for device-free localization in RF sensor networks |
CA2802747A1 (en) * | 2010-07-13 | 2012-01-19 | Univfy Inc. | Method of assessing risk of multiple births in infertility treatments |
US10271876B2 (en) | 2011-11-23 | 2019-04-30 | Mezadata Medical Ip Holding Llc | Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells |
US8999728B2 (en) * | 2011-12-21 | 2015-04-07 | Church & Dwight Co., Inc. | Diagnostic detection device |
US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
US20180306815A1 (en) * | 2014-11-18 | 2018-10-25 | Siemens Healthcare Diagnostics Inc. | Lateral flow assay ratio test |
US20190080800A1 (en) * | 2017-04-06 | 2019-03-14 | Celmatix Inc. | Methods for assessing the potential for reproductive success and informing treatment therefrom |
US10603075B1 (en) | 2018-11-30 | 2020-03-31 | Ohana Biosciences, Inc. | Compositions and methods for enhancing sperm function |
WO2024037724A1 (en) | 2022-08-19 | 2024-02-22 | Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) | Methods for improving sperm function and fertilizing ability for assisted reproduction techniques |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444879A (en) | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
US4514505A (en) | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
WO1988004779A1 (en) | 1986-12-22 | 1988-06-30 | University Of Queensland | Method of treatment of mammals using antibodies to early pregnancy factor (epf) |
US5260421A (en) | 1987-12-21 | 1993-11-09 | Applied Research Systems Ars Holding N.V. | Site-directed mutagenesis modified glycoprotein hormones |
EP0553301A1 (de) | 1990-10-17 | 1993-08-04 | Yale University | Verfahren zum nachweis und zur verlaufsverfolgung von krebs, schwangerschaft und krankheit des trophoblasten |
JPH04300896A (ja) | 1991-03-29 | 1992-10-23 | Hiroshi Sueoka | ヒト由来の早期妊娠因子及びその分離・精製法 |
US6339143B1 (en) * | 1993-05-13 | 2002-01-15 | The Trustees Of Columbia University In The City Of New York | Methods of using antibodies against hormone-related determinants |
WO1998010282A1 (en) * | 1996-09-06 | 1998-03-12 | Yale University | Prenatal screening for down's syndrome using hyperglycosylated gonadotropin |
DE69624920T2 (de) | 1996-09-27 | 2003-09-18 | Inverness Medical Switzerland Gmbh, Zug | Testreagentien und Testvorrichtungen |
US7198954B1 (en) * | 1999-02-03 | 2007-04-03 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by hCG assay |
US6927034B2 (en) | 1998-02-03 | 2005-08-09 | The Trustees Of Columbia University In The City Of New York | Methods for detecting trophoblast malignancy by HCG assay |
US6500627B1 (en) | 1998-02-03 | 2002-12-31 | The Trustees Of Columbia University In The City Of New York | Methods for predicting pregnancy outcome in a subject by HCG assay |
US6627457B2 (en) | 2001-07-30 | 2003-09-30 | Quest Diagnostics Investments Incorporated | Methods for detecting pregnancy |
KR101301979B1 (ko) | 2010-12-21 | 2013-08-30 | 주식회사 케이티 | 근거리 통신을 위한 액세스 포인트를 이용한 위치 측정 방법 및 장치와 액세스 포인트의 위치 추정 방법 |
-
1999
- 1999-05-13 US US09/311,428 patent/US6927034B2/en not_active Expired - Lifetime
-
2000
- 2000-05-12 WO PCT/US2000/013197 patent/WO2000070094A1/en active IP Right Grant
- 2000-05-12 EP EP00935949A patent/EP1183390B8/de not_active Expired - Lifetime
- 2000-05-12 CA CA2372666A patent/CA2372666C/en not_active Expired - Lifetime
- 2000-05-12 DE DE60025347T patent/DE60025347T2/de not_active Expired - Lifetime
- 2000-05-12 AU AU51334/00A patent/AU778130B2/en not_active Ceased
- 2000-05-12 IL IL14645400A patent/IL146454A0/xx active IP Right Grant
- 2000-05-12 AT AT00935949T patent/ATE395812T1/de not_active IP Right Cessation
- 2000-05-12 NZ NZ516024A patent/NZ516024A/xx not_active IP Right Cessation
-
2001
- 2001-11-12 IL IL146454A patent/IL146454A/en not_active IP Right Cessation
-
2004
- 2004-09-01 US US10/931,956 patent/US7285391B2/en not_active Expired - Fee Related
-
2007
- 2007-10-22 US US11/975,936 patent/US7790403B2/en not_active Expired - Fee Related
-
2010
- 2010-09-07 US US12/807,513 patent/US7993858B2/en not_active Expired - Fee Related
-
2011
- 2011-07-12 US US13/180,845 patent/US8163508B2/en not_active Expired - Fee Related
-
2012
- 2012-04-13 US US13/446,723 patent/US8420339B2/en not_active Expired - Fee Related
-
2013
- 2013-03-18 US US13/846,172 patent/US8802381B2/en not_active Expired - Fee Related
-
2014
- 2014-07-15 US US14/332,156 patent/US20150010926A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8163508B2 (en) | 2012-04-24 |
CA2372666C (en) | 2010-02-09 |
US20030003597A1 (en) | 2003-01-02 |
EP1183390B8 (de) | 2006-05-03 |
ATE395812T1 (de) | 2006-01-15 |
EP1183390B1 (de) | 2006-01-04 |
WO2000070094A1 (en) | 2000-11-23 |
US7993858B2 (en) | 2011-08-09 |
US6927034B2 (en) | 2005-08-09 |
US8802381B2 (en) | 2014-08-12 |
US7790403B2 (en) | 2010-09-07 |
CA2372666A1 (en) | 2000-11-23 |
US8420339B2 (en) | 2013-04-16 |
IL146454A0 (en) | 2002-07-25 |
DE60025347T2 (de) | 2006-09-14 |
US20050042702A1 (en) | 2005-02-24 |
EP1183390A4 (de) | 2003-05-07 |
US20080108089A1 (en) | 2008-05-08 |
EP1183390A1 (de) | 2002-03-06 |
US20130011858A1 (en) | 2013-01-10 |
US20150010926A1 (en) | 2015-01-08 |
AU5133400A (en) | 2000-12-05 |
AU778130B2 (en) | 2004-11-18 |
US7285391B2 (en) | 2007-10-23 |
US20110300557A1 (en) | 2011-12-08 |
NZ516024A (en) | 2004-03-26 |
IL146454A (en) | 2007-10-31 |
US20140087393A1 (en) | 2014-03-27 |
US20110159526A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60025347D1 (de) | Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests | |
WO1999041584A3 (en) | METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY | |
WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
WO2006126008A3 (en) | Improved immunoassay methods | |
ATE519109T1 (de) | Präeklampsie-diagnose | |
WO2004089187A3 (en) | Caries risk test for predicting and assessing the risk of disease | |
ATE289685T1 (de) | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben | |
ATE312342T1 (de) | Bestimmung eines midregionalen proadrenomedullin- teilpeptids in einer biologischen flüssigkeit zu diagnostischen zwecken sowie immunoassays für die durchführung einer solchen bestimmung | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
DE60228557D1 (de) | Candida-nachweis | |
EP1571160A4 (de) | Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper | |
DE60232248D1 (de) | Schwangerschaftsnachweisverfahren | |
DE50104561D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente | |
WO2005071407A3 (en) | Methods of diagnosing acute coronary syndrome by measuring urotensin ii | |
ATE462975T1 (de) | Verfahren zum immunochemischen testen des anti- hm1.24-antikörpers | |
ATE427494T1 (de) | Verfahren zur quantifizierung der akt-protein- expression | |
ATE420364T1 (de) | Verfahren zur magenkrebsvorhersage | |
FI990990A0 (fi) | Menetelmä disakkaridaasien määrittämiseksi ja testipakkaus sitä varten | |
ATE437368T1 (de) | Verfahren zum prüfen von mit wt1-verbundenen krankheiten | |
CA2586654A1 (en) | Use of asc as a marker for colorectal cancer | |
GB0001089D0 (en) | Lipoprotein assay | |
BRPI0415562A (pt) | reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma | |
DE60038557D1 (en) | Assay | |
of the United | Biological markers: maintaining standards | |
SE0003662D0 (sv) | Assay method and kit therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |